This study examined the effects of 20 weeks of administration of conjugated linoleic acids/omega-3 fatty acids with or without programed resistance exercise training on body composition, skeletal muscle properties and functional capacity in middle-aged mice fed a high-fat diet. r What is the main finding and its importance?
Introduction
Sarcopenia, the progressive loss of muscle mass and strength, is considered one of the primary factors that impair quality of life in the ageing population (Morley et al. 2001) . The sarcopenic process may be accompanied by an increase in fat mass, particularly in the intramuscular and visceral adipose tissues. The coexistence of these alterations in body composition, described as 'sarcopenic obesity' (Roubenoff, 2004) , has led to the hypothesis of the link between an increase in adipose tissue and the development of sarcopenia (Schrager et al. 2007; Tardif et al. 2014) . Fat accumulation can negatively affect protein turnover in skeletal muscle and thus decrease muscle mass. For instance, obese individuals exhibit impaired protein anabolic responses to insulin and amino acids in skeletal muscle (Guillet et al. 2009) , and high-fat diet-induced increases in adipose tissue and intramuscular ceramides have been shown to decrease muscular protein synthesis (Tardif et al. 2014) .
In addition, a potential mechanism by which increased adipose tissue contributes to this catabolic process may be explained by the actions of inflammatory cytokines, which are abundantly expressed and released from visceral adipose tissue (Fontana et al. 2007) . Inflammation mediates muscle wasting by impairing protein turnover (White et al. 2012 ) and myogenic capacity (Trendelenburg et al. 2012) . In particular, overexpressed pro-inflammatory cytokines may promote sarcopenia through induction of the cysteine-aspartic proteases (caspase) cascade (Marzetti & Leeuwenburgh, 2006) , activation of nuclear factor-κB (Frost & Lang, 2005) and reduced insulin-like growth factor-I (IGF-I) concentration (Mourkioti & Rosenthal, 2005) . Therefore, it could be speculated that obesity aggravates sarcopenia and/or accelerates the onset of sarcopenia. In fact, Bollheimer et al. (2012) reported that high-fat diet (HFD)-induced muscular lipid content is inversely correlated with hindlimb muscle mass of old rats. Furthermore, we recently reported that myofibre cross-sectional area (CSA) was significantly reduced in middle-aged mice fed long-term HFD compared with a control diet, and this catabolic process appeared to be driven by impaired myogenic capacity (Lee et al. 2015) . These findings point to the inter-relationships between prolonged HFD-induced obesity and age-related muscle wasting.
Resistance exercise training (RET) has been previously demonstrated as a cost-effective intervention to improve muscle mass and strength (Davis et al. 2011 (Davis et al. , 2013 ; however, aged muscles display blunted hypertrophic responses to RET compared with young cohorts (Kim et al. 2005) . These impaired adaptive responses might stem from slower rates of recovery (Roth et al. 2000) and a blunted acute inflammatory response (Hamada et al. 2005) , causing defective repair and regeneration of damaged muscle. Although chronic inflammation is closely associated with sarcopenia, the acute inflammatory response to a bout of exercise promotes repair and regeneration of damaged myofibres through provision of growth factors (Dennis et al. 2008) . Therefore, a complementary intervention strategy (e.g. anti-inflammatory supplements) to attenuate chronic inflammation at rest while simultaneously sensitizing the acute inflammatory response to exercise would be necessary to facilitate regeneration of skeletal muscle.
Conjugated linoleic acids (CLA) and omega-3 polyunsaturated fatty acids (n-3) have attracted great attention for their health-enhancing properties. Although CLA and n-3 possess anti-inflammatory properties (Bassaganya-Riera et al. 2002; Browning, 2003) , each remains unique, because these fatty acids contain antioxidant (Leung & Liu, 2000; Arab et al. 2006) and muscle anabolic properties (Gingras et al. 2007) , respectively. Furthermore, previous studies reported that CLA and n-3 supplementation enhances RET-induced benefits by increasing muscle mass (Pinkoski et al. 2006) and muscular strength (Rodacki et al. 2012; Da Boit et al. 2017 ) to a greater extent. Regarding this, it is conceivable that CLA and/or n-3 administration could enhance the benefits of RET on the muscle phenotype, thereby improving functional capacity in the elderly. Therefore, the purpose of the present study was to investigate the impact of 20 weeks of CLA/n-3 administration independently or combined with programmed RET on the skeletal muscle properties in middle-aged mice fed a HFD. It was hypothesized that both CLA/n-3 administration and RET would positively modulate HFD-induced consequences in body composition, functional capacity and myofibre CSA in middle-aged mice. Furthermore, CLA/n-3 administration would enhance RET-induced benefits when combined with RET.
Methods

Ethical approval
All experimental procedures were conducted in compliance with the Animal Welfare Act (USDA) and S.-R. Lee and others (Grundy, 2015) . Body weight and food consumption were measured weekly. Animals were monitored daily by animal care and research technicians for signs or distress, pain, injury or disease. A university veterinarian was summoned to the facility in the event that any of these situations arose, to minimize pain and distress during all experimental procedures consistent with the journal's policies and regulations.
Animals and overall experimental design
Eight-month-old C57BL/6 male mice were housed singly in a temperature-controlled room on a 12 h-12 h light-dark cycle. After a 1 month acclimation period, all animals underwent the first set of in vivo dual energy X-ray absorptiometry (DXA) and functionality assessments. After acclimation, animals (9 months old) were randomly assigned into one of four experimental groups (n = 10 per group), as follows: (i) high-fat diet control (H); (ii) H + RET (HE); (iii) H + CLA/n-3 (HCN); and (iv) H + RET + CLA/n-3 (HECN). Once the 20 week intervention was completed, animals underwent post-intervention DXA and functionality measurements. They were then killed, and skeletal muscle tissues (gastrocnemius, soleus and quadriceps) were collected at 14 months of age for post-intervention in vitro analyses (i.e. muscle wet weight and myofibre CSA, the number of satellite cells and myonuclei, and mRNA expression).
Resistance exercise training
Programmed RET was conducted for RET groups using the ladder climbing resistance exercise protocol. The ladder climbing apparatus was 100 cm in length at 85 deg, with grips 2 cm apart (Lee et al. 2004) . A weight was attached to the base of the tail with a foam clip. The RET groups were trained three times per week for 20 weeks with ladder climbing. The RET protocol was adapted from a previous study that reported significant increases in muscle mass (23.3%) after 8 weeks of RET (Lee et al. 2004) . Briefly, the initial load was 50% of their body weight and increased progressively (10% of body weight on a biweekly basis) through the training period. The training protocol consisted of four sets of three repetitions with a 1 min rest between repetitions and 2 min rest between sets.
Administration of CLA/n-3 mix
During the acclimation period, all animals were fed the normal laboratory diet. After acclimation, the animals were given high-fat diets (60% fat, D12492; Research Diets, New Brunswick, NJ, USA) for 20 weeks. The CLA/n-3 diets were administered with 1% of CLA (0.5% of cis-9, trans-11 and 0.5% of trans-10, cis-12) and 1% of polyunsaturated fatty acids (PUFA) enriched in n-3 fatty acids (Vital Pharmaceuticals, Inc., Weston, FL, USA). The composition of the experimental diets is provided in Table 1 . Daily portions of meals were stored in sealed plastic bags at −20°C to minimize oxidation of the fatty acids. Fresh food was served in the morning on each day throughout the experimental period, and old food was discarded. Daily food consumption was measured every day. Upon termination of the study, the average amount of total and daily consumption was calculated.
Body composition using dual energy X-ray absorptiometry
As described in our previous studies (Kim et al. 2012; Park et al. 2013; Lee et al. 2015) , mice were anaesthetized and their whole body was assessed in vivo by dual energy X-ray absorptiometry (iDXA; GE Medical Systems, Madison, WI, USA) to determine total body mass (TBM) and fat mass (FM). The DXA measurements were performed before and after the 20 week experimental protocol.
Sensorimotor coordination (inclined plane) test
This test of sensorimotor coordination required the mice to maintain their body position for 5 s on an inclined plane while the angle of the surface was changed from 20 to 60 deg at 2 deg intervals (Kim et al. 2012; Park et al. 2013; Lee et al. 2015) . The animal was given a maximum of three trials at any given angle and scored as a 'fail' if all three trials were unsuccessful. The angle was then reduced by 2 deg and repeated after a rest period of at least 5 min in the cage.
Grip strength test
The animals' forelimbs were placed on a tension bar while they were restrained manually by the scruff of the neck and base of the tail (Kim et al. 2012; Park et al. 2013; Lee et al. 2015) . The animals were gently pulled back until they released their grip from the bar. The force generated as they attempted to maintain their grip was measured (in grams) by a strain gauge (DFS-101; Ametek, Berwyn, PA, USA). Each animal was subjected to three trials, with the greatest force of the three trials being the criterion measure.
Muscle tissue collection
Once all experimental procedures were completed, animals were killed by overdose with isoflurane via vaporizer (ࣙ5%) for collection of vital organs and skeletal muscle. Exposure to isoflurane was maintained for 1 min after the cessation of breathing, with confirmation of death by removal of the vital organs. Skeletal muscles (gastrocnemius, soleus and quadriceps) were rapidly excised, weighed, and snap frozen in liquid nitrogen. The gastrocnemius muscle from the left hindlimb was then removed and mounted cross-sectionally, followed by freezing in liquid nitrogen for immunohistochemical analyses. All isolated tissues were stored at −80°C for later analyses (Kim et al. 2012; Park et al. 2013; Lee et al. 2015) .
RNA isolation and RT-PCR
The RT-PCR procedure was used to measure target mRNA levels as described previously (Adams et al. 1999) . After total RNA was isolated from frozen muscle samples via TRI reagent, cDNA was synthesized by reverse transcription. To assess the inflammatory state, we analysed muscle mRNA expression of tumour necrosis factor-α (TNF-α; forward 5 -CTCCCTCCAGAAAAGACACCAT-3 , reverse 5 -CACCCCGAAGTTCAGTAGACAG-3 ), interleukin-1β (IL-1β; forward 5 -TCCCTTTTCGTGAATGAGCA GA-3 , reverse 5 -ATCCCCCACACGTTGACAGC-3 ), interleukin-6 (IL-6; forward 5 -AACCACGGCCTTCCCT ACTT-3 , reverse 5 -GCCATTGCACAACTCTTTTCTC-3 ) and interleukin-15 (IL-15; forward 5 -AACCCATG TCAGCAGATAACCA-3 , reverse 5 -TGACACAGCCCA AAATGAAGAC-3 ). For assessment of protein turnover, we measured mammalian target of rapamycin (mTOR; forward 5 -GCCCACGCCTGCCATACTTG-3 , reverse 5 -TCAGCTCCGGGTCTTCCTTGTT-3 ) for protein synthesis and atrogin-1 (forward 5 -CGTGCACGGCCA ACAACC-3 , reverse 5 -CCCGCCAACGTCTCCTCAAT-3 ) and muscle ring finger-1 (MuRF1; forward 5 -GG CTGCGAATCCCTACTGG-3 , reverse 5 -TGATCTTCTC GTCTTCGTGTTCCT-3 ) for protein degradation. Insulin-like growth factor-IEa (forward 5 -ATCTGCC TCTGTGACTTCTTGA-3 , reverse 5 -CTGGAGCCATA GCCTGTG-3 ) was analysed as a positive mitogenic regulator. Lastly, caspase-3 (forward 5 -CGGGGTACGG AGCTGGACTGT-3 , reverse 5 -TGCTGCAAAGGGACT GGATGAA-3 ), caspase-8 (forward 5 -CAAGGCCCGG GAAGACATAA-3 , reverse 5 -TCACCGTGGGATAGGA TACAGC-3 ) and caspase-9 (forward 5 -GCCCAGCAG GTGACCGAGATAG-3 , reverse 5 -ACAGGGGAGGGCA CATTTTCAA-3 ) were analysed for apoptosis signalling. For each PCR, 18S (324 bp product) was co-amplified with each target gene (mRNA) to provide a ratio of target mRNA/18S. Twenty-four microlitres of the 25 μl PCR product was separated by electrophoresis (100 V) in 2% agarose gel (Bio-Rad, Hercules, CA, USA), pre-mixed with ethidium bromide solution (0.1 μg ml −1 ; Bio-Rad). Gels were run with molecular weight markers (100 bp Hyper Ladder, exACTGene, Thermo Fisher Scientific, Fair Lawn, NJ, USA) to confirm the expected sizes of each mRNA. The primer and 18S bands detected were captured under UV light via a Bio-Rad ChemiDoc TM XRS imaging system, and the density of each band was quantified with a Bio-Rad Quantity One R software (Bio-Rad).
Immunohistochemistry and determination of myofibre area
Immunohistochemical analyses were used to evaluate the CSA of myofibres and quantify the numbers of satellite cells and myonuclei as previously described (Lee et al. 2015) . Briefly, tissue sections 6 μm thick were made using a cryostat (Microm HM 525 Cryostat, Kalamazoo, MI, USA). Once sections were fixed in 3% neutral-buffered formalin for 45 min, 5% goat serum was applied to block the sections in PBS at room Sections were rinsed with PBS followed by 5 min in deionized water. Mayer's Haematoxylin was used to counterstain nuclei for 5 min, followed by rinses in warm, running tap water and distilled water. As a result of staining, myonuclei and satellite cells were identified as blue and brown, respectively. High-resolution (48-bit TIFF) images were captured at ×40 magnification. Myofibre CSA was analysed using ImageJ software (US National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
All data are presented as means ± SD. A 4 (experimental conditions) × 2 (time: pre-and post-treatment) repeated-measures ANOVA was used to analyse the in vivo (i.e. DXA-determined body composition and functionality) measurements, whereas a one-way ANOVA was used to analyse the in vitro data (i.e. muscle weight, myofibre CSA, numbers of satellite cells and myonuclei, and mRNA expression). Significance was set at P ࣘ 0.05. When the overall ANOVA was significant, post hoc comparisons were performed using Fisher's least significance difference (LSD) tests to maximize statistical power.
Results
Body composition and functional capacity
Repeated measurements were performed for in vivo body composition and functional capacity both pre-(9 months of age) and post-intervention (14 months of age). The specific values for body composition and functional capacity are shown in Table 2 .
Body composition. There was a significant group × time interaction for FM. There was no difference in FM between groups pre-intervention. Fat mass increased significantly in H (+74 ± 82%, P = 0.026), HE (+142 ± 81%, P < 0.001) and HECN (+43 ± 48%, P = 0.014) from pre-to post-intervention, but no change was found in HCN. HE exhibited significantly higher FM than H (P = 0.014) and HECN (P = 0.001) post-intervention. HCN demonstrated significantly lower FM than both H (P = 0.014) and HE (P < 0.001) postintervention. Abbreviations: H, high-fat diet; HE, high-fat diet plus resistance exercise; HCN, high-fat diet plus CLA/n-3; and HECN, high-fat diet plus resistance exercise plus CLA/n-3. Values are means ± SD. n = 10 per group. * P ࣘ 0.05, significantly different from H. † P ࣘ 0.05, significantly different from HCN.
Sensorimotor function (inclined plane test).
There was a significant group × time interaction for sensorimotor function. There was no difference in sensorimotor function between groups pre-intervention. Sensorimotor function substantially decreased over time only in H (−11 ± 19%, P = 0.001), with the post-training value being significantly less than HE (P = 0.001), HCN (P = 0.006) and HECN (P < 0.001). In contrast, sensorimotor function significantly increased from baseline only in HECN (+17 ± 11%, P < 0.001), and was significantly higher than in HE (P = 0.016) and HCN (P = 0.003) postintervention.
Grip strength. There was a significant group × time interaction for grip strength. There was no difference in grip strength between groups pre-intervention. A significant decrease in grip strength from baseline was found in H (−15 ± 9%, P < 0.001) and HCN (−17 ± 9%, P < 0.001), whereas a significant increase from baseline was found in HE (+9 ± 10%, P = 0.002) and HECN (+22 ± 13%, P < 0.001). HE and HECN exhibited significantly greater strength than H and HCN (P < 0.001) post-intervention.
Muscle mass (muscle wet weight)
The specific values for muscle mass are shown in Table 3 . Cross-sectional comparisons were performed for in vitro analyses (i.e. muscle wet weight, histology and mRNA expression) post-intervention (at 14 months of age). Both RET groups (HE and HECN) had significantly greater gastrocnemius wet weight than H (+41%, P = 0.006-0.007) and HCN (+34%, P = 0.012-0.014). Soleus wet weight in HE was significantly higher than in H (+39%, P < 0.001) and HCN (+26%, P = 0.003). HECN also showed a significantly greater soleus wet weight than H and HCN (P < 0.001), by 50 and 36%, respectively. Quadriceps wet weight in HE was significantly higher than in H (+35%, P = 0.009) and HCN (+35%, P = 0.006). HECN also had significantly higher quadriceps weight than H (+35%, P = 0.010) and HCN (+35%, P = 0.007).
Myofibre cross-sectional area, satellite cells and myonuclei
Histological data are presented in Fig. 1 . HE exhibited significantly higher muscle fibre CSA than H (+27%, P = 0.001). HCN had substantially lower muscle fibre CSA than HE (−18%, P = 0.005). HECN also had significantly greater muscle fibre CSA than H (+30%, P < 0.001) and HCN (+24%, P < 0.001; Fig. 1B) . In comparison to H, satellite cell abundance and the number of myonuclei were significantly higher in HE (+21, P = 0.002 and +14%, P < 0.001, respectively), HCN (+29%, P = 0.006 and +21%, P < 0.001, respectively) and HECN (+19%, P = 0.006 and +16%, P < 0.001, respectively) after the 20 week intervention (Fig. 1C and D) .
Expression of mRNAs regulating muscle mass
Regulators of inflammation. In comparison to H, relative mRNA expression of TNF-α in the gastrocnemius was significantly lower in HE (−39%, P = 0.032), HCN (−24%, P = 0.046) and HECN (−21%, P = 0.038) ( Fig. 2A) . There was no significant group difference in mRNA levels of IL-1β, IL-6 ( Fig. 2A) and IL-15 (Fig. 2B) . In the soleus, IL-15 mRNA concentration in HCN was significantly greater than in H (+62%, P = 0.040). Furthermore, HECN exhibited remarkably higher IL-15 concentration compared with H (+97%, P = 0.004) and HE (+69%, P = 0.011; Fig. 2B ).
Regulators of protein turnover. In the gastrocnemius, mTOR mRNA expression showed no detectable difference between groups (Fig. 2C ). No significant difference was found in IGF-IEa mRNA expression in the soleus (Fig. 2C ).
There was no noticeable difference in mRNA expression for atrogin-1 or MuRF1 (Fig. 2D) .
Regulators of apoptosis. In the gastrocnemius, caspase-3 mRNA expression was significantly higher in HCN than in HE (+102%, P = 0.021; Fig. 2E ). HECN had lower caspase-3 levels than HCN (−41%, P = 0.066; Fig. 2E ). HE tended to show lower expression of this apoptosis mediator than H (−46%, P = 0.065; Fig. 2E ). There was no significant difference in caspase-8 and -9 among groups (Fig. 2E ). Abbreviations: H, high-fat diet; HE, high-fat diet plus resistance exercise; HCN, high-fat diet plus CLA/n-3; and HECN, high-fat diet plus resistance exercise plus CLA/n-3. n = 10 per group. Values are means ± SD.
Discussion
The major findings of this study were that CLA/n-3 ameliorated high-fat diet-mediated body weight gain and fat accumulation (Table 2; H versus HCN), while also preserving some aspects of function (i.e. inclined plane; Table 2 ). In addition, CLA/n-3 improved myogenic capacity by expanding the number of satellite cells and myonuclei ( Fig. 1C and D) , reduced the expression of a pro-inflammatory cytokine (i.e. TNF-α; Fig. 2A) and increased the abundance of an anti-inflammatory cytokine (i.e. IL-15; Fig. 2B ) in middle-aged mice during HFD-induced catabolism. CLA/n-3 alone was unable to increase muscle mass or fibre cross-sectional area compared with high-fat diet control animals (Table 3 and Fig. 1B) , nor was it able to mitigate HFD-induced loss of grip strength (Table 2 ). In contrast, both RET groups (i.e. HE and HECN) showed greater muscle mass and myofibre size versus high-fat diet control animals ( TNF-α Gas IL-1β Gas IL-6 Gas mTOR Gas Atrogin-1 Gas MuRF1 Gas
Cap-3 Gas Cap-8 Gas Cap-9 Gas Abbreviations: H, high-fat diet; HE, high-fat diet plus resistance exercise; HCN, high-fat diet plus CLA/n-3; and HECN, high-fat diet plus resistance exercise plus CLA/n-3. n = 10 per group. Values are means ± SD.
S.-R. Lee and others and Fig. 1B) , as well as improved grip strength over time ( Table 2 ), suggesting that RET rather than CLA/n-3 is primarily responsible for improvements in muscle mass and strength. Given that there was a significant expansion of fat mass with resistance training and high-fat feeding (i.e. HE group; Table 2 ), but a lesser degree of fat gain in HECN (Table 2) , combined CLA/n-3 and RET may offer an opportunity to obtain the muscular benefits of resistance training while concurrently minimizing fat gain.
Body composition and function
The changes in body composition after the 20 weeks of high-fat diet were comparable to previous investigations. For instance, adult mice fed a high-fat diet for 24 weeks were reported to have a final body weight of ß40-45 g (McGillicuddy et al. 2013 ), a value which is similar to the final body weight of ß40 g in our high-fat diet group (H group). In a separate study, body mass gain in C57BL/6 mice after 24 weeks on high-fat diet was reported to be ß8-13 g depending on sex (Gallou-Kabani et al. 2007) . This is fairly similar to the ß8 g total body mass gain in the present study. Regarding the DXA-determined fat mass, similar longitudinal studies using the same technique were difficult to locate; however, a close proxy, which measured fat mass by DXA, reported 24 week high-fat diet-fed mice to have 34-37% fat (Gallou-Kabani et al. 2007 ). Although we observed ß60% fat mass after 20 weeks of high-fat diet (H group), our mice were already into middle age at the end of the study (14 months old), in comparison to 6 months of age in the study by Gallou-Kabani et al. (2007) , and this may have contributed to the discrepancy. In addition to the high-fat diet control (H group), several other high-fat diet groups, including HE and HECN, showed significantly increased TBM; however, TBM was maintained in HCN, suggesting that CLA/n-3 administration attenuated the HFD-induced increase in TBM (Table 2 ). This improvement was associated with blunted FM gain ( Table 2) . These outcomes concurred with previous studies demonstrating the anti-lipogenic effects of CLA (Yamasaki et al. 2003) and n-3 (Ikemoto et al. 1996) in various rodent species. Furthermore, Sneddon et al. (2008) demonstrated that CLA/n-3 supplementation prevented FM gain in young obese humans. Although CLA/n-3 administration appears to be beneficial as a fat-reducing agent, there were no significant additive effects with concurrent RET (Table 2) . Although the mechanism explaining the actions of CLA and n-3 on fat metabolism remains to be established, upregulation of peroxisome proliferator activated receptor-α, which enhances lipid metabolism and insulin signalling in skeletal muscle, would facilitate the lipid-lowering process (Inoue et al. 2006; Shirouchi et al. 2007 ).
It has been suggested that CLA/n-3 treatment possibly combats muscle wasting by attenuating negative regulators of muscle mass. For instance, Rahman et al. (2009) reported that 24 weeks of CLA administration in middle-aged mice produced greater increases in lean body mass and muscle wet weight compared with a control group. This improvement was driven by relatively lower oxidative stress and inflammatory status in CLA-fed middle-aged mice compared with their counterpart controls during ageing. Conjugated linoleic acids has also been shown to provide additive effects on RET-induced muscle hypertrophy. Young individuals who completed 7 weeks of RET with 5 g day −1 of CLA had greater lean body mass gains compared with a placebo group (+1.4 versus +0.2 kg; Pinkoski et al. 2006) . With CLA, n-3 also has shown anabolic properties in animal and human studies. Chronic intake of n-3 stimulated upregulation of Akt-mTOR-P70 ribosomal protein S6 kinase (S6K1) signalling, a prominent pathway for protein synthesis in steers (Gingras et al. 2007) . The anabolic properties of n-3 were also observed in human research. Smith et al. (2011) reported that daily n-3 intake (1.86 g eicosapentaenoic acid and 1.50 g docosahexaenoic acid) for 8 weeks improves muscle protein synthesis in the elderly. Moreover, combined CLA/n-3 administration for 12 weeks increased lean body mass by 2.4% in obese individuals (Sneddon et al. 2008) . Overall, chronic CLA/n-3 administration appears to improve body composition alone and in conjunction with RET.
Interestingly, grip strength decreased in both H and HCN from baseline ( Table 2 ), indicating that CLA/n-3 treatment was not effective for preserving generation of maximal tension. This is consistent with the finding that muscle mass was not different between the two groups (Table 3) . However, muscle weight was improved by RET with or without CLA/n-3. Thus, it seems that the strength gains were associated with increased muscle mass via mechanical loading, but CLA/n-3 administration failed to exert any additive effects.
Furthermore, there was a significant decline in sensorimotor function in H, no change in HE and HCN, but a significant increase in HECN (Table 2) . This indicated that CLA/n-3 administration or RET independently attenuated the decline in sensorimotor function during chronic HFD, but with greater benefits when the two were combined (Table 2) . Overall, impaired muscle strength during HFD was improved mainly by RET, whereas CLA/n-3 administration enhanced the RET-induced improvement in sensorimotor function. In accordance with our result, a previous study reported that although chronic RET improves muscular strength for older women, daily fish oil consumption can enhance RET-induced improvements in muscular strength, physical function (Rodacki et al. 2012 ) and muscle quality (Da Boit et al. 2017) . Future research will be needed to support these findings.
Myofibre cross-sectional area, satellite cells and myonuclear abundance
We observed significantly lower myofibre CSA in H and HCN compared with HE and HECN (Fig. 1B) . These findings suggest that CLA/n-3 treatment alone was unable to combat HFD-induced catabolism. In contrast, programmed RET, by itself or in combination with CLA/n-3, increased myofibre size and the numbers of satellite cells and myonuclei despite HFD (Fig. 1B-D) .
Satellite cells, the primary source of new myonuclei, participate in the regenerative process and mechanical loading-induced muscle hypertrophy (Adams, 2006) . Therefore, the decrement in satellite cell abundance in catabolic environments (e.g. ageing) may stimulate muscle atrophy. Resistance exercise training is a potent stimulator of muscle hypertrophy that increases satellite cell activity and the number of myonuclei. Supporting this assertion, Kadi & Thornell (2000) reported that 10 weeks of RET greatly increased myofibre CSA (+36%) and expanded the number of myonuclei (+70%) and satellite cells (+46%). Based on our findings and prior evidence, it could be proposed that RET rather than CLA/n-3 administration improved myogenic capacity in the face of HFD.
Transcripts related to muscle mass regulation
Regulators for inflammation. Tumour necrosis factor-α, IL-1β, IL-6 and IL-15 were measured as markers of inflammation. Chronic inflammation, with increased pro-inflammatory cytokine concentrations along with decreased growth factor levels, contributes to muscle wasting (Ross, 1999) . We found a significantly greater TNF-α mRNA expression in the gastrocnemius of H compared with HE, HCN and HECN ( Fig. 2A) . Given that TNF-α mediates IGF-I resistance and provokes muscle catabolism (Steinberg et al. 2006) , our data suggest that CLA/n-3, independently or combined with RET, might be beneficial for preserving muscle mass by antagonizing the expression of this pro-inflammatory cytokine.
Our findings are in agreement with those of Greiwe et al. (2001) , who reported that RET reduced muscle TNF-α mRNA levels and increased protein synthesis in the elderly, demonstrating the anti-inflammatory impact of chronic RET during ageing. In support of the anti-inflammatory effect of CLA, Inoue et al. (2006) reported a significant reduction in TNF-α concentration in skeletal muscle with increased insulin sensitivity in rats fed CLA. The anti-inflammatory effect of n-3 has also been reported by Schmocker et al. (2007) , who found that transgenic fat-1 mice, which endogenously form n-3 from n-6, showed lower blood and hepatic TNF-α concentrations in response to lipopolysaccharide treatment compared with control animals.
Interleukin-15, the most abundant cytokine in skeletal muscle, has anti-inflammatory, anabolic and anticatabolic properties (Carbó et al. 2000; Furmanczyk & Quinn, 2003) . For instance, IL-15 treatment has shown to combat apoptosis in skeletal muscle of tumour-bearing rats by downregulating TNF-α signaling through blockade of the TNF receptor 1 and 2. (Figueras et al. 2004) . Interleukin-15 also appears to promote anabolism by suppressing protein degradation (Carbó et al. 2000) , while inducing an accumulation of myosin heavy chain in differentiated myotubes in human cell cultures (Furmanczyk & Quinn, 2003) . In the present study, H exhibited significantly lower IL-15 mRNA expression in the soleus compared with both CLA/n-3 groups (HCN and HECN; Fig. 2B ). Moreover, IL-15 mRNA expression was significantly greater in HECN than in HE (Fig. 2B ). This suggests that CLA/n-3 administration promoted anabolic and anti-inflammatory effects despite the HFD.
Regulators for protein turnover. Insulin-like growth factor-IEa mRNA expression in the soleus tended to be greater in HECN than in H (P = 0.12) and HE (P = 0.12; Fig. 2C ), suggesting that CLA/n-3 combined with RET had a possible mitogenic effect. Although it failed to reach significance, there was greater atrogin-1 expression in H than in HE (P = 0.12; Fig. 2D ). In contrast, MuRF1 mRNA expression tended to be higher in HCN versus the RET groups (HE, P = 0.11; HECN, P = 0.13; Fig. 2D ). Based on these findings, it is possible that protein degradation through E-3 ligases might be ameliorated to some degree by RET.
Regulators for apoptosis. Caspases, a group of cysteine proteases, play a significant role in apoptosis. Caspase-8 and -9 initiate apoptosis, whereas capspase-3 is a final executioner of the programme, leading to eventual cell death and sarcopenia (Budihardjo et al. 1999 ). The present study reported a higher concentration of caspase-3 in HCN compared with HE (P < 0.05) and HECN (P = 0.06; Fig. 2E ). Likewise, H exhibited a tendency for greater caspase-3 mRNA expression compared with HE (P = 0.06; Fig. 2E ). There was a similar pattern observed for caspase-8, as H and HCN tended to show higher caspase-8 levels than HE (P = 0.10 and P = 0.11, respectively; Fig. 2E ). Therefore, it appeared that CLA/n-3 treatment did not affect caspase mRNA expression with chronic HFD; however, programmed RET lowered caspase-3 and -8 abundance versus H, suggesting that RET might be able to minimize the induction of apoptotic signalling by HFD and combat the sarcopenic process.
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Conclusion
Our findings suggest that CLA/n-3 administration may attenuate fat mass gain and improve myogenic capacity, but without significant effects on strength and muscle mass, in middle-aged mice that consumed long-term HFD. By itself, RET appeared to attenuate loss of muscle mass and functional capacity in the HFD-induced catabolic environment. This may possibly be mediated by improvements in the inflammatory state and myogenic capacity. Furthermore, programmed RET prevented HFD-induced deficits in sensorimotor function, with the greatest improvement in conjunction with CLA/n-3 administration. Overall, the present study suggests that muscle mass and strength were mainly improved by programmed RET under HFD, with little effects from CLA/n-3. However, CLA/n-3 treatment may be at least partly efficacious in improving myogenic capacity (i.e. satellite cells) and anabolic signalling (i.e. IL-15 and IGF-IEa) during HFD-induced catabolism in middle-aged rodents. Future clinical trials may need to be conducted to investigate the therapeutic values of the CLA/n-3 treatment plan further, to improve aspects of health and functional capacity.
